Page 9 - Pfizer

Pfizer to acquire cancer drugmaker Trillium Therapeutics for $2.3 bn

Pfizer will pay $18.50 a share for Cambridge, Massachusetts-based Trillium, the companies said Monday in a statement.

Pfizer and Astra vaccines less effective after 90 days, says study

The Oxford University study found that 90 days after a second shot of the Pfizer or Astra vaccine, their efficacy in preventing infections had slipped to 75 per cent and 61 per cent, respectively

Pfizer, AstraZeneca vaccines less effective against Delta variant: Study

The COVID vaccines by Pfizer and AstraZeneca are less effective against the Delta variant compared to the Alpha variant, according to a study led by researchers at the University of Oxford

Covid vaccines fight off infections but less effective against delta: Study

Results from UK survey are likely to fuel calls to give booster shots to the fully vaccinated.

Covid-19 pandemic: US okays third jab for those with low immunity

The amended emergency use authorization paves the way for people who have had an organ transplant, or those with a similar level of weakened immune system, to get an extra dose

Moderna Covid vaccine 76% effective against Delta, Pfizer 42%: Study

Covid-19 jabs that were developed by US drug makers Pfizer and Moderna may not be as effective against the 'Delta' variant compared to as they were against the original strain of the virus, says study

RDIF proposes Pfizer conduct joint trial with Sputnik Light as booster shot

The Russian Direct Investment Fund (RDIF) has proposed that US drugmaker Pfizer start joint trials with Sputnik Light as a booster COVID-19 vaccine shot, the RDIF said on Wednesday."Delta cases surge in US & Israel shows mRNA vaccines need a heterogeneous booster to strengthen & prolong immune response. #SputnikV pioneered mix & match approach, combo trials & showed 83.1% efficacy vs Delta. Today RDIF offers Pfizer to start trial with Sputnik Light as booster," it said in a Tweet.It further said that Sputnik V is the first in the world to offer combo trial to AstraZeneca in November 2020, co-sponsored mix & match trials with AstraZeneca, Moderna and Sinopharm."Sputnik V was the 1st in the world to offer combo trial to AstraZeneca in Nov 2020, co-sponsored mix & match trials with AstraZeneca, Moderna & Sinopharm. Since then heterogeneous boosting pioneered by Sputnik proved to be effective vs mutations," it added further.According to an official ...

Pfizer shares hit record high with Covid-19 vaccine stocks on a tear

The percentage gain was the stock's biggest one-day rise since Nov. 9, when Pfizer released positive data for its Covid-19 vaccine

BioNTech says has supplied more than 1 billion Covid vaccine doses so far

BioNTech and partner Pfizer have supplied more than one billion doses of their vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca the German biotech Group said

J&J seeks approval for single-dose Covid-19 vaccine in India

It is not clear whether J&J is seeking indemnity against adverse events following vaccination like its US peers

Pfizer, Moderna raise prices for Covid-19 vaccines in European Union

The terms of the deals were renegotiated after Phase 3 clinical trial data showed vaccines from the two companies are more effective than some rivals

India may soon have Covid-19 vaccines for children. All you need to know

Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above

World Coronavirus Dispatch: Israel offers Pfizer booster jab to the 60-plus

China says it has made alternative proposal for virus origin probe, EU pulls ahead of US in vaccinations, and other pandemic-related news across the globe

Pfizer raises sales forecast for Covid vaccine by almost a third to $33 bn

The New York drugmaker had previously projected vaccine sales for the year of $26 billion.

Top headlines: Pfizer raises sales forecast; Maruti misses estimates in Q1

Business Standard brings you the top headlines on Wednesday

Pfizer, Astra vaccine antibody levels may decline after 2-3 months: Lancet

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to The Lancet journal

Covid LIVE: Delhi records zero fatality, 2nd time since onset of 2nd wave

The number of people who have recuperated from the disease has surged to 30,503,166, while the case fatality rate stands at 1.34 per cent

US to buy 200 million more doses of Pfizer vaccine, says White House

The federal government is buying 200 million more doses of the Pfizer coronavirus vaccine to prepare for future needs, such as boosters and shots for kids under 12

No domestic vaccine maker has sought indemnity: Junior Health Minister

Bharti Pravin Pawar says Centre has set up team to deal with various issues related to procurement of Covid-19 vaccine from foreign firms

Discussing indemnity, other issues with foreign Covid vaccine makers: Govt

A team of central government officials is in continuous dialogue with foreign Covid vaccine manufactures like Pfizer, Moderna and Johnson and Johnson to discuss and address various issues